Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Anaesthesia and Intensive Care
Medicine
Opthalmology & Visual Sciences
Orthopaedics and Trauma
Psychiatry
Surgery
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-9 of 9 (Search time: 0.002 seconds).
previous
1
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker, B.
;
Guilhot, F.
;
O'Brien, S.
;
Gathmann, I.
;
Kantarjian, H.
;
Gattermann, N.
;
Deininger, M.
;
Silver, R.
;
Goldman, J.
;
Stone, R.
;
Cervantes, F.
;
Hochhaus, A.
;
Powell, B.
;
Gabrilove, J.
;
Rousselot, P.
;
Reiffers, J.
;
Cornelissen, J.
;
Hughes, T.
;
Agis, H.
;
Fischer, T.
;
et al.
2008
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
le Coutre, P.
;
Ottmann, O.
;
Giles, F.
;
Kim, D.
;
Cortes, J.
;
Gattermann, N.
;
Apperley, J.
;
Larson, R.
;
Abruzzese, E.
;
O'Brien, S.
;
Kuliczkowski, K.
;
Hochhaus, A.
;
Mahon, F.
;
Saglio, G.
;
Gobbi, M.
;
Kwong, Y.
;
Baccarani, M.
;
Hughes, T.
;
Martinelli, G.
;
Radich, J.
;
et al.
2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M.
;
Deininger, M.
;
Rosti, G.
;
Hochhaus, A.
;
Soverini, S.
;
Apperley, J.
;
Cervantes, F.
;
Clark, R.
;
Cortes, J.
;
Guilhot, F.
;
Hansen-Hjorth, H.
;
Hughes, T.
;
Kantarjian, H.
;
Kim, D.
;
Larson, R.
;
Lipton, J.
;
Mahon, F.
;
Martinelli, G.
;
Mayer, J.
;
Muller, M.
;
et al.
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
O'Brien, S.
;
Guilhot, F.
;
Larson, R.
;
Gathmann, I.
;
Baccarani, M.
;
Cervantes, F.
;
Cornelissen, J.
;
Fischer, T.
;
Hochhaus, A.
;
Hughes, T.
;
Lechner, K.
;
Nielsen, J.
;
Rousselot, P.
;
Reiffers, J.
;
Saglio, G.
;
Shepherd, J.
;
Simonsson, B.
;
Gratwohl, A.
;
Goldman, J.
;
Kantarjian, H.
;
et al.
2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Nieborowska-Skorska, M.
;
Kopinski, P.
;
Ray, R.
;
Hoser, G.
;
Ngaba, D.
;
Flis, S.
;
Cramer, K.
;
Reddy, M.
;
Koptyra, M.
;
Penserga, T.
;
Glodkowska-Mrowka, E.
;
Bolton, E.
;
Holyoake, T.
;
Eaves, C.
;
Cerny-Reiterer, S.
;
Valent, P.
;
Hochhaus, A.
;
Hughes, T.
;
Van der Kuip, H.
;
Sattler, M.
;
et al.
2011
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
Esposito, N.
;
Colavita, I.
;
Quintarelli, C.
;
Sica, A.
;
Peluso, A.
;
Luciano, L.
;
Picardi, M.
;
Vecchio, L.
;
Buonomo, T.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Russo, D.
;
Branford, S.
;
Saglio, G.
;
Vaz de Melo, J.
;
Martinelli, R.
;
Ruoppolo, M.
;
Kalebic, T.
;
Martinelli, G.
;
et al.
2018
Role of the β common (βc) family of cytokines in health and disease
Hercus, T.
;
Kan, W.
;
Broughton, S.
;
Tvorogov, D.
;
Ramshaw, H.
;
Sandow, J.
;
Nero, T.
;
Dhagat, U.
;
Thompson, E.
;
Tung Shing, K.
;
McKenzie, D.
;
Wilson, N.
;
Owczarek, C.
;
Vairo, G.
;
Nash, A.
;
Tergaonkar, V.
;
Hughes, T.
;
Ekert, P.
;
Samuel, M.
;
Bonder, C.
;
et al.
2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2)
Broman, K.K.
;
Hughes, T.
;
Dossett, L.
;
Sun, J.
;
Kirichenko, D.
;
Carr, M.J.
;
Sharma, A.
;
Bartlett, E.K.
;
Nijhuis, A.A.G.
;
Thompson, J.F.
;
Hieken, T.J.
;
Kottschade, L.
;
Downs, J.
;
Gyorki, D.E.
;
Stahlie, E.
;
van Akkooi, A.
;
Ollila, D.W.
;
Frank, J.
;
Song, Y.
;
Karakousis, G.
;
et al.
2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Eroglu, Z.
;
Broman, K.K.
;
Thompson, J.F.
;
Nijhuis, A.
;
Hieken, T.J.
;
Kottschade, L.
;
Farma, J.M.
;
Hotz, M.
;
Deneve, J.
;
Fleming, M.
;
Bartlett, E.K.
;
Sharma, A.
;
Dossett, L.
;
Hughes, T.
;
Gyorki, D.E.
;
Downs, J.
;
Karakousis, G.
;
Song, Y.
;
Lee, A.
;
Berman, R.S.
;
et al.
Discover
Author
5
Hochhaus, A.
3
Baccarani, M.
3
Cervantes, F.
3
Guilhot, F.
3
Kantarjian, H.
3
Larson, R.
3
Martinelli, G.
3
O'Brien, S.
3
Saglio, G.
2
Apperley, J.
.
next >
Subject
5
Antineoplastic Agents
5
Benzamides
5
Imatinib Mesylate
5
Piperazines
5
Pyrimidines
4
Adult
4
Female
4
Fusion Proteins, bcr-abl
4
Male
3
Aged
.
next >
Date issued
2
2020 - 2022
4
2010 - 2019
3
2003 - 2009